Back to List
Sookjin Lee
Chief Business Officer (CBO) | Ph.D.
A business expert leading innovation in precision medicine and genomics for 20 years. Accelerating the commercialization of innovative technologies with academic expertise and market insight.
Which Children with Motor Speech Disorders Should Be Prioritised for Genetic Testing?
Insights | 26. 05. 15
[Clinical Review] Why WGS Achieves up to 44.4% Diagnostic Yield in NDD: Insights from a 100-Family Italian Study
Insights | 26. 02. 20
Diagnostic Yield of WES in Infantile HCM with Normal CMA: A Case of PTPN11-associated Noonan Syndrome
Diagnostic story | 26. 02. 13
Genetic Mechanisms of GDD with Normal MRI: WES Strategies to End the Diagnostic Odyssey
Insights | 26. 02. 10
Prolonged Febrile Seizures and Developmental Plateau in a 7-Month-Old Infant: Beyond Simple Febrile Convulsions
Rare disease series | 26. 02. 09
Progressive Neurodevelopmental Regression and Refractory Epilepsy in a 36-Month-Old Female: A Clinical Correlation
Rare disease series | 26. 02. 09
